Molecular genetics of metachromatic leukodystrophy

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Metachromatic leukodystrophy (MLD) is a fatal lysosomal storage disorder.
• It results from arylsulfatase A (ARSA) deficiency, leading to progressive demyelination and severe neurological symptoms.
• MLD presents with clinical heterogeneity, classified into distinct forms based on age of onset.

Purpose of the Study:

• To investigate the genotype-phenotype correlation in MLD.
• To differentiate MLD from ARSA pseudodeficiency.
• To improve diagnostic accuracy and genetic counseling for MLD.

Main Methods:

• Gene cloning and characterization of ARSA mutations.
• Analysis of allele distribution in patients with different MLD forms.
• Identification and characterization of mutations causing pseudodeficiency.

Main Results:

• A strong genotype-phenotype correlation was established, linked to residual ARSA enzyme activity.
• Severe MLD forms are associated with null ARSA alleles, while milder forms correlate with low residual activity.
• Pseudodeficiency alleles, causing substantial ARSA deficiency in healthy individuals, were identified.

Conclusions:

• Residual enzyme activity is a key determinant of MLD clinical presentation.
• Distinguishing MLD from pseudodeficiency is crucial for accurate diagnosis and genetic counseling.
• Characterization of pseudodeficiency mutations enhances diagnostic capabilities for MLD.